 |
|
The Autonomic and Hemodynamic Effects of Oral Theophylline in Patients With Vasodepressor Syncope
Steven D. Nelson, MD;
Mary Stanley, MS;
Charles J. Love, MD;
Kelly S. Coyne;
Stephen F. Schaal, MD
Arch Intern Med. 1991;151(12):2425-2429.
Abstract
| |
Adenosine appears to be an important mediator of hypotension and bradycardia in certain subsets of patients with vasodepressor syncope. Adenosine receptor blockade with methylxanthines may hypothetically prevent the vasodepressor spell. We studied the chronotropic, hemodynamic, and cardiac autonomic responses to head-up tilt in patients (mean age 40.7 ±18.1 years) with vasodepressor syncope before and after treatment with oral theophylline. At baseline, hypotension and syncope or near syncope were induced at 11.7±2.3 minutes of 60° head-up tilt in all patients. Cardiac vagal and sympathetic tone showed biphasic and directionally opposite changes during tilt. Repeat tilt during oral theophylline therapy (6-12 mg/kg/day for 14±6 days) did not provoke symptomatic hypotension in 82% of patients, During 10.7±6.1 months of follow-up, seven patients had no recurrence of vasodepressor syncope and seven patients discontinued theophylline because of adverse reactions. Low-dose theophylline prevents tilt-induced vasodepressor syncope and may prevent spontaneous vasodepressor syncope in selected patients who can tolerate theophylline.
(Arch Intern Med. 1991;151:2425-2429)
Author Affiliations
From the Division of Cardiology, Department of Internal Medicine, The Ohio State University, Columbus.
Footnotes
Accepted for publication June 18, 1991.
Presented in part at the American Heart Association National Convention, Dallas, Tex, November 15, 1990.
Reprint requests to Division of Cardiology, The Ohio State University Hospitals, 663 Means Hall, 1654 Upham Dr, Columbus, OH 43210 (Dr Nelson).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Vasovagal syncope in the older patient.
Tan and Parry
J Am Coll Cardiol 2008;51:599-606.
ABSTRACT
| FULL TEXT
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
Madrid et al.
J Am Coll Cardiol 2001;37:554-559.
ABSTRACT
| FULL TEXT
The management of vasovagal syncope
Parry and Kenny
QJM 1999;92:697-705.
FULL TEXT
Pharmacotherapy of Neurally Mediated Syncope
Benditt et al.
Circulation 1999;100:1242-1248.
ABSTRACT
| FULL TEXT
Role of Adenosine Receptors in the Paradoxic Bradycardia Response of Rats to Inferior Vena Cava Occlusion During an Infusion of Isoproterenol
Waxman and Asta
Circulation 1998;98:1228-1235.
ABSTRACT
| FULL TEXT
Prediction of Head-Up Tilt Test Result by Analysis of Early Heart Rate Variations
Mallat et al.
Circulation 1997;96:581-584.
ABSTRACT
| FULL TEXT
The Value of Tilt Table Testing With Isoproterenol in Determining Therapy in Adults With Syncope and Presyncope of Unexplained Origin
Tonnessen et al.
Arch Intern Med 1994;154:1613-1617.
ABSTRACT
Evaluation and Management of the Patient With Syncope
Kapoor
JAMA 1992;268:2553-2560.
ABSTRACT
|
